PRAME and cancer: There was an obvious relationship between the high expression of PRAME and shorter OS in Asian patients with cancer (HR = 1.41, 95% CI: 1.02–1.95, P < 0.001) and non-Asian patients with cancers (HR = 2.36, 95% CI: 1.81–3.08, P < 0.001).